List To Watch: Cliffs Natural Resources (NYSE:CLF), Revance Therapeutics (NASDAQ:RVNC), Prima Biomed (NASDAQ:PBMD), Ophthotech Corporation (NASDAQ:OPHT)

Posted by on Mar 11, 2016

On 10 March, Piper Jaffray Companies (NYSE:PJC) shares advanced 0.07% and was closed at $45.40. PJC EPS growth in last 5 year was 25.30%. Piper Jaffray Companies (NYSE:PJC) year to date (YTD) performance is 12.38%.

Piper Jaffray Companies (NYSE:PJC) announce the hiring of Jason Harkness as a managing director in its technology investment banking group. He will work in partnership with Michael Hirsch, serving as co-heads of the internet & digital media sectors, and based in the firm’s San Francisco office

Cliffs Natural Resources Inc. (NYSE:CLF) shares decreased -3.88% in last trading session and ended the day at $2.48. CLF Gross Margin is 11.70% and its has a return on assets of -32.40%. Cliffs Natural Resources Inc. (NYSE:CLF) quarterly performance is 17.54%.

On 29 February, Cliffs Natural Resources Inc. (NYSE:CLF) announced the expiration and final results of its private offers (the “Exchange Offers”) to certain eligible holders to exchange its newly issued 8.00% 1.5 Lien Senior Secured Notes due 2020 (the “New 1.5 Lien Notes”) for certain outstanding notes of Cliffs listed in the table below (the “Existing Notes”).

Revance Therapeutics, Inc. (NASDAQ:RVNC) caters to the Healthcare space. Its weekly performance is -13.56%. On the last day of trading company shares ended up at $17.34. Revance Therapeutics, Inc. (NASDAQ:RVNC) distance from 50-day simple moving average (SMA50) is 0.27%.

Revance Therapeutics, Inc. (NASDAQ:RVNC) announced that clinical results from the company’s BELMONT Phase 2 active comparator study of DaxibotulinumtoxinA for Injection (RT002) were reported in a podium presentation at the American Academy of Dermatology (AAD) annual meeting, which is being held in Washington, DC, March 4-8, 2016.

Prima Biomed Ltd. (NASDAQ:PBMD) shares moved up 25.58% in last trading session and ended the day at $1.08. Prima Biomed Ltd. (NASDAQ:PBMD) quarterly performance is -6.09%.

Prima Biomed Ltd. (NASDAQ:PBMD) has received notification from the Listing Qualifications Department of The NASDAQ Stock Market (the “Staff”) indicating that, for the period from January 13, 2016 through February 26, 2016, the closing bid price of the Company’s American Depositary Shares, or ADS, had not been maintained at the minimum required closing bid price of at least US$1.00 per share as required for continued listing on The NASDAQ Global Market pursuant to NASDAQ Listing Rule 5450(a)(1) (the “Minimum Bid Price Rule”).

Ophthotech Corporation (NASDAQ:OPHT) caters to the Healthcare space. Its weekly performance is -10.28%. On the last day of trading company shares ended up at $40.66. Ophthotech Corporation (NASDAQ:OPHT) distance from 50-day simple moving average (SMA50) is -18.28%.

Ophthotech Corporation (NASDAQ:OPHT) had its target price dropped by stock analysts at Citigroup Inc. from $128.00 to $91.00 in a research note issued to investors on Friday,StockTargetPrices.com reports. Citigroup Inc.’s price objective points to a potential upside of 99.04% from the stock’s previous close.

Leave a Reply

Your email address will not be published. Required fields are marked *